A major breakthrough in cancer study is occurring with the use of VHH fragments to reactivate mutated p53. This vital malignant suppressor protein is frequently disabled in many types of tumors, causing uncontrolled https://mediajx.com/story297846/mini-antibodies-restore-the-p53-protein-a-potential-hope-for-malignant-therapy